- Investing Ideas
- /
- German Biotech Stocks
German Biotech Stocks
Results
16
16 companies
Merck KGaA
Market Cap: €53.1b
Operates as a science and technology company in Germany.
MRK
€122.20
7D
-5.2%
1Y
-21.4%
Bayer
Market Cap: €20.9b
Operates as a life science company worldwide.
BAYN
€21.27
7D
-6.2%
1Y
-25.5%
SCHOTT Pharma KGaA
Market Cap: €3.4b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXP
€22.58
7D
-6.0%
1Y
-43.2%
Gerresheimer
Market Cap: €2.2b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€64.35
7D
-14.2%
1Y
-38.1%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany.
DMP
€36.50
7D
-4.2%
1Y
10.9%
Evotec
Market Cap: €1.0b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€5.90
7D
-2.9%
1Y
-58.2%
Formycon
Market Cap: €402.6m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.80
7D
-6.6%
1Y
-51.0%
PharmaSGP Holding
Market Cap: €295.0m
Manufactures and sells over-the-counter drugs and other healthcare products in Germany.
PSG
€24.60
7D
1.7%
1Y
11.8%
MPH Health Care
Market Cap: €106.2m
An investment company, engages in the healthcare business in Germany.
93M1
€23.20
7D
3.6%
1Y
5.5%
Apontis Pharma
Market Cap: €94.5m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€11.35
7D
-0.9%
1Y
61.2%
2invest
Market Cap: €71.3m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€12.40
7D
0%
1Y
44.2%
Cantourage Group
Market Cap: €54.1m
Operates as a medical cannabis company in Europe.
HIGH
€4.34
7D
-4.4%
1Y
-48.9%
Biofrontera
Market Cap: €15.1m
A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
B8FK
€2.49
7D
-3.3%
1Y
-64.8%
Medigene
Market Cap: €10.4m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.70
7D
-55.3%
1Y
-84.0%
co.don
Market Cap: €6.5m
Does not have significant operations.
CNW
€0.24
7D
0%
1Y
-84.5%
Sangui Biotech International
Market Cap: €419.8k
Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.
SBH
€0.002
7D
0%
1Y
-77.8%